Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

Malmström, Annika, Dr ; Grønberg, Bjørn Henning, PhD ; Marosi, Christine, MD ; Stupp, Roger, MD ; Frappaz, Didier, MD ; Schultz, Henrik, MD ; Abacioglu, Ufuk, MD ; Tavelin, Björn, BSc ; Lhermitte, Benoit, MD ; Hegi, Monika E, PhD ; Rosell, Johan, MSc ; Henriksson, Roger, Prof

The lancet oncology, 2012-09, Vol.13 (9), p.916-926 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível